A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis

Neurology

Volumn 48, Issue 2, 1997, Pages 312-314

  Miller, A E ^a,b   Morgante, L A ^a   Buchwald, L Y ^c   Nutile, S M ^c   Coyle, P K ^d   Krupp, L B ^d   Doscher, C A ^d   Lublin, F D ^e   Knobler, R L ^e   Trantas, F ^e   Kelley, L ^e   Smith, C R ^f   La Rocca, N ^f   Lopez, S ^f  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c MOUNT AUBURN HOSPITAL   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f Multiple Sclerosis Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HUMAN; INFECTION RATE; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031029071     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.2.312     Document Type: Article

References (12)

1. Prevention and control of influenza: vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1994;43(RR-9):1-13.
2. Miller H, Cendrowski W, Schapira K. Multiple sclerosis and vaccination. BMJ 1967;2:210-213.
3. Rabin J. Hazard of influenza vaccine in neurologic patients. JAMA 1973;225:63-64.
4. Sibley WA, Bamford CR, Laguna JF. Influenza vaccination in patients with multiple sclerosis. JAMA 1978;236:1965-1966.
5. Bamford CR, Sibley WA, Laguna JF. Swine influenza vaccination in patients with multiple sclerosis. Arch Neurol 1978;35: 242-243.
6. Myers LW, Ellison GW, Lucia M, et al. Swine influenza virus vaccination in multiple sclerosis. J Infect Dis 1977;136:S546-554.
7. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
8. Borenstein M, Cohen J. Statistical power analysis: a computer program. Hillsdale, NJ: Lawrence Earlbaum Associates, 1988.
9. The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind placebo-controlled trial. Neurology 1993;43:655-661.
10. Jacobs L, Cookfair D, Rudick R, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996;39:285-294.
11. Johnson KP, Brooks BR, Cohen JA, et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 1995;45:1268-1276.
12. Goodkin DE, Hertsgaard D, Rudick RA. Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis: implications for clinical trials. Arch Neurol 1989;46:1107-1112.